et al. Prospective correlative assessment of biomarkers in E4599 randomized phase III trial of carboplatin and paclitaxel±bevacizumab in advanced non-small cell lung cancer (NSCLC). - Dowlati,A.; Gray,R.; Johnson,D. (J Clin Oncol, 2006)